How does levosimendan compare to other inodilators in terms of efficacy in treating septic shock and improving patient outcomes?
Abstract
Levosimendan shows variable efficacy in septic shock compared to other inodilators like dobutamine and milrinone. While improvements in cardiac function are noted, its impact on mortality is inconsistent, and it is associated with higher morbidity and costs.
Fields of Study & Subjects
Sepsis Diagnosis and Treatment
Heart Failure Treatment and Management
Hemodynamic Monitoring and Therapy
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 January 2026